Literature DB >> 16950007

Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays--an update.

Sonia R Pagliusi1, Joakim Dillner, Michael Pawlita, Wim G V Quint, Cosette M Wheeler, M Ferguson.   

Abstract

International reference materials such as International Standard reagents facilitate quality assurance of essential biopharmaceutical products and related in vitro diagnostic tests. Standardization of antibody and DNA measurements and harmonization of laboratory procedures are key to the success of cancer prevention strategies through screening methods as well as for development and implementation of vaccination against the human papillomavirus (HPV). The WHO supported the preparation and initial analysis of a panel of candidate serological and DNA reference reagents aimed at facilitating inter-laboratory comparisons and detection of HPV worldwide. Two international collaborative studies assessed the performance of various HPV antibody and HPV-DNA detection assays and examined the feasibility of generating HPV antibody and DNA standard reagents. These studies showed that improvement in performance and comparability of assays is urgently needed and that the use of the same International Standard reference reagent could significantly improve performance and comparability. It is hoped that the establishment of International Units and International Standards for HPV antibody and DNA analysis will be pursued with high priority.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16950007     DOI: 10.1016/j.vaccine.2006.06.016

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Human papillomavirus vaccines launch a new era in cervical cancer prevention.

Authors:  Meenakshi Dawar; Shelley Deeks; Simon Dobson
Journal:  CMAJ       Date:  2007-08-28       Impact factor: 8.262

2.  Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection.

Authors:  Christine C Roberts; Ryan Swoyer; Janine T Bryan; Frank J Taddeo
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

3.  Human papillomaviruses as therapeutic targets in human cancer.

Authors:  Karin Hellner; Karl Münger
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

4.  Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens.

Authors:  Colomba Giorgi; Paola Di Bonito; Felicia Grasso; Stefania Mochi; Luisa Accardi; Maria Gabriella Donà; Margherita Branca; Silvano Costa; Luciano Mariani; Alberto Agarossi; Marco Ciotti; Kari Syrjänen
Journal:  Infect Agent Cancer       Date:  2008-06-26       Impact factor: 2.965

5.  The effectiveness of vaccination to prevent the papillomavirus infection: a systematic review and meta-analysis.

Authors:  Herney Andrés García-Perdomo; Julio Cesar Osorio; Adrian Fernandez; James Alejandro Zapata-Copete; Andrés Castillo
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

6.  Utilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class II Homo sapiens.

Authors:  Ridla Bakri; Arli Aditya Parikesit; Cipta Prio Satriyanto; Djati Kerami; Usman Sumo Friend Tambunan
Journal:  Adv Bioinformatics       Date:  2014-08-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.